TAA expression in AML determined by DNA microarray–based gene expression profiling. (A-H) Kaplan Meier analyses based on G250/CA9, PRAME, RHAMM/HMMR, WT1, TERT, PRTN3, BCL2, and LAMR1 expression levels (P values are indicated; expression values have been dichotomized by the median with higher expression levels color-coded in red and lower levels in green).